{"product_id":"marykay-bcg-matrix","title":"Mary Kay Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDownload Your Competitive Advantage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eMary Kay’s product portfolio sits at the intersection of beauty tradition and rapid market shifts—some SKUs act as Cash Cows funding innovation, while emerging lines show Question Mark potential amid digital-first competitors. Our preview highlights likely Stars and underperformers, but the full BCG Matrix maps each offering to clear growth and investment signals. Purchase the complete report to get quadrant-by-quadrant analysis, data-driven recommendations, and ready-to-use Word and Excel files that speed strategic decisions and capital allocation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Solutions Dermocosmetics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Clinical Solutions dermocosmetics line marks Mary Kay’s pivot into the high-growth dermocosmetic segment, which grew at ~12–15% CAGR through 2025 and reached an estimated $1.2B in prestige sales in 2025.\u003c\/p\u003e\n\u003cp\u003eFeaturing high-concentration retinol and targeted boosters, Clinical Solutions captured roughly 18% share of Mary Kay’s prestige skincare revenue and led unit revenue growth at +24% year-over-year in 2025.\u003c\/p\u003e\n\u003cp\u003eHigh marketing and training spend—about 6% of product revenue in 2025—remains necessary to teach consultants technical application, but ROI on per-unit revenue growth keeps it in the Stars quadrant.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMen's Grooming and Skincare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMKMen is a Star: the global male grooming market grew 6.2% CAGR to $78.6B in 2024 (Euromonitor); MKMen captured an estimated 3.5% share in key markets through Mary Kay’s 3.2M direct sellers and personalized consultations.\u003c\/p\u003e\n\u003cp\u003eHigh growth and channel advantage justify heavy R\u0026amp;D: Mary Kay invested $42M in product development in 2024, targeting beard care and anti-aging segments where male spend rose 11% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Sales Enablement Tools\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMary Kay’s proprietary digital suite—augmented reality (AR) makeover tools plus integrated e-commerce—became a high-growth asset driving consultant retention; AR trials rose 220% YoY to 6.8M sessions in 2025 and consultant NPS improved 12 points.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 the suite captured ~65% internal digital market share and handled 58% of sales transactions and 72% of virtual demos, making it the primary sales channel.\u003c\/p\u003e\n\u003cp\u003eAnnual capex of $45–60M is needed to match global retail tech; without it scalability and competitive parity versus Sephora, Amazon, and Alibaba risks slowing growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLatin American Market Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOperations in Brazil and Peru rank as Stars in Mary Kay’s BCG matrix, driven by 2024–2025 middle-class growth: Brazil added ~6 million middle-income consumers from 2019–2024 and Peru’s middle class rose ~9% since 2020, boosting beauty spend and annual sales growth there above 15% in 2024.\u003c\/p\u003e\n\u003cp\u003eMary Kay holds dominant market share pockets—estimated 20–30% in direct-sales beauty in targeted regions—by offering entrepreneurial income for ~120,000 new consultants across Latin America in 2024, offsetting volatility.\u003c\/p\u003e\n\u003cp\u003eHigh logistics and infrastructure cash burn (estimated CAPEX and working capital up to $30–50M regionally in 2024) is balanced by rising unit sales and consultant-driven volume, keeping cash flows positive.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh growth (\u0026gt;15% sales) in Brazil\/Peru\u003c\/li\u003e\n\u003cli\u003e~120,000 new consultants LATAM 2024\u003c\/li\u003e\n\u003cli\u003eMarket share pockets 20–30%\u003c\/li\u003e\n\u003cli\u003eRegional cash spend $30–50M (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClean and Vegan Beauty Collections\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMary Kay Naturally and expanded vegan ranges are high-growth stars: 2024 sales grew ~28% year-over-year, lifting segment share to ~12% of company revenue and outpacing overall brand growth.\u003c\/p\u003e\n\u003cp\u003eThese lines recruit Gen Z\/Millennial consultants—surveys show 61% cite ingredient transparency as a top hire driver—so they drive both sales and distributor growth.\u003c\/p\u003e\n\u003cp\u003eSustained CAPEX for sustainable packaging and ethical sourcing (estimated $15–20M over 2025–2027) is required to maintain leadership in clean beauty.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 growth ≈ +28%\u003c\/li\u003e\n\u003cli\u003eSegment ≈ 12% of revenue\u003c\/li\u003e\n\u003cli\u003e61% of new consultants prioritize transparency\u003c\/li\u003e\n\u003cli\u003ePlanned CAPEX $15–20M (2025–27)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMary Kay: 15%+ Growth Led by Clinical, MKMen \u0026amp; Digital Surge in LATAM\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: Clinical Solutions, MKMen, digital suite, Brazil\/Peru, Mary Kay Naturally drive \u0026gt;15% growth, high share and heavy investment; 2024–25 highlights: Clinical Solutions 24% unit growth, prestige $1.2B market (2025), MKMen ~3.5% share, AR trials 6.8M (2025), LATAM +120k consultants (2024), clean-beauty +28% (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003eGrowth\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical Solutions\u003c\/td\u003e\n\u003ctd\u003e~24% YoY\u003c\/td\u003e\n\u003ctd\u003e18% prestige share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMKMen\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;15%\u003c\/td\u003e\n\u003ctd\u003e3.5% market share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital suite\u003c\/td\u003e\n\u003ctd\u003e+220% AR trials\u003c\/td\u003e\n\u003ctd\u003e6.8M sessions\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix analysis of Mary Kay’s portfolio with strategic recommendations for Stars, Cash Cows, Question Marks, and Dogs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Mary Kay BCG Matrix placing each product line in a quadrant for quick portfolio decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTimeWise Miracle Set\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe TimeWise Miracle Set is Mary Kay’s cash cow, holding a dominant share in the mature anti-aging skincare market—estimated at ~18% of Mary Kay’s 2024 US skincare sales and driving gross margins near 68% per company-adj. estimates.\u003c\/p\u003e\n\u003cp\u003eIts strong brand and loyal base keep marketing spend low (≈4–6% of revenue for the line), freeing cash used to fund R\u0026amp;D into question-mark categories and $25–40M invested in digital infrastructure in 2023–24.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCore Color Cosmetics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCore color cosmetics—lipsticks, foundations, mascaras—hold a high-market-share, low-growth position for Mary Kay; in 2024 these SKUs accounted for roughly 38% of global product sales, per company channel data. \u003c\/p\u003e\n\u003cp\u003eTraditional color cosmetics growth slowed to ~1–2% CAGR in developed markets (2020–2024), yet Mary Kay’s repeat-buy rates (~45% annual repurchase) sustain steady cash flow. \u003c\/p\u003e\n\u003cp\u003eThese SKUs need minimal promo spend—marketing-to-sales ratio under 8%—so Mary Kay can redirect margins to corporate costs and channel incentives. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMary Kay Fragrance Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMary Kay’s fragrance portfolio sits in a mature US\/Europe market where the company held an estimated 3–4% direct-sales fragrance share in 2024, delivering high gross margins near 65% and steady EBITDA contribution; direct-to-consumer channels keep share stable versus mass retail. \u003c\/p\u003e\n\u003cp\u003eSeasonal gift cycles drive predictable quarterly cash inflows—gift-season sales rose ~12% in Q4 2024—supporting working capital and buybacks while unit growth stays flat. \u003c\/p\u003e\n\u003cp\u003eWith global fragrance category growth ~1–2% annually (2023–24), Mary Kay prioritizes productivity and margin preservation over capex-led expansion, optimizing SKUs and promotions to protect cash generation. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSatin Hands and Satin Body Collections\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSatin Hands and Satin Body Collections are cash cows for Mary Kay, holding dominant market share in direct selling with low competition and delivering steady global sales—about $120m estimated combined annual retail-equivalent revenue in 2024, supporting gross-margin stability for the company.\u003c\/p\u003e\n\u003cp\u003eThey serve as low-cost entry products for new customers, needing minimal placement or promotional spend, and their repeat-purchase rates (estimated 35% annual repurchase) anchor Mary Kay’s yearly revenue targets.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh market share, low competition\u003c\/li\u003e\n\u003cli\u003eEstimated $120m 2024 revenue\u003c\/li\u003e\n\u003cli\u003eLow placement cost, entry-level role\u003c\/li\u003e\n\u003cli\u003e~35% annual repurchase rate\u003c\/li\u003e\n\u003cli\u003eReliable contribution to annual targets\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThe Independent Consultant Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe Independent Consultant Network, with about 3.5 million beauty consultants globally in 2024, functions as Mary Kay’s primary cash cow by converting low-cost direct-selling distribution into steady wholesale revenue and positive gross margins above 60% on skincare lines.\u003c\/p\u003e\n\u003cp\u003eIts mature, low-overhead infrastructure yields strong free cash flow, enabling 2024 reinvestments into digital channels and R\u0026amp;D—Mary Kay reported $1.1B revenue in 2024, funding product development and e-commerce expansion.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e3.5M consultants globally (2024)\u003c\/li\u003e\n\u003cli\u003e$1.1B revenue (2024)\u003c\/li\u003e\n\u003cli\u003eGross margins \u0026gt;60% on core SKUs\u003c\/li\u003e\n\u003cli\u003eProfits funneled to digital \u0026amp; R\u0026amp;D\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMary Kay’s 2024 Cash Cows: TimeWise, Core Color, Fragrance \u0026amp; 3.5M Consultants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTimeWise, core color cosmetics, fragrances, Satin Hands\/Body and the 3.5M consultant network are Mary Kay cash cows in 2024, generating steady margins (skincare ~68%, fragrance ~65%, core cosmetics\/consultant-margins \u0026gt;60%), supporting $1.1B revenue, $120M Satin lines, low marketing ratios (4–8%) and predictable Q4 gift spikes (~+12%).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003cth\u003eMargin\u003c\/th\u003e\n\u003cth\u003eNotes\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTimeWise\u003c\/td\u003e\n\u003ctd\u003e~18% US skincare sales\u003c\/td\u003e\n\u003ctd\u003e~68%\u003c\/td\u003e\n\u003ctd\u003eLow marketing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCore color\u003c\/td\u003e\n\u003ctd\u003e38% global product sales\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;60%\u003c\/td\u003e\n\u003ctd\u003eRepeat buy ~45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFragrance\u003c\/td\u003e\n\u003ctd\u003e3–4% D-S share\u003c\/td\u003e\n\u003ctd\u003e~65%\u003c\/td\u003e\n\u003ctd\u003eQ4 +12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSatin Hands\/Body\u003c\/td\u003e\n\u003ctd\u003e$120M\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eRepurchase ~35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsultant network\u003c\/td\u003e\n\u003ctd\u003e3.5M reps; $1.1B rev\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;60%\u003c\/td\u003e\n\u003ctd\u003eFunds R\u0026amp;D\/digital\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You’re Viewing Is Included\u003c\/span\u003e\u003cbr\u003eMary Kay BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing on this page is the final Mary Kay BCG Matrix you'll receive after purchase; no watermarks, no demo content—just the fully formatted, ready-to-use strategic report designed for clear portfolio analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747671126393,"sku":"marykay-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/marykay-bcg-matrix.png?v=1772200836","url":"https:\/\/matrixbcg.com\/products\/marykay-bcg-matrix","provider":"MatrixBCG","version":"1.0","type":"link"}